Recruiting
Phase 1
Phase 2

A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer

Sponsor:

Arvinas Androgen Receptor, Inc.

Code:

NCT05067140

Conditions

Prostate Cancer Metastatic

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ARV-766 Part A&B

ARV-766 + Abiraterone Part C&D

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information